He, X., Huang, Y., Li, B., Gong, C. X. & Schuchman, E. H. Deregulation of sphingolipid metabolism in Alzheimer’s disease. Neurobiol Aging 31, 398–408, https://doi.org/10.1016/j.neurobiolaging.2008.05.010 (2010).
Couttas, T. A. et al. Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis. Acta Neuropathol Commun 2, 9, https://doi.org/10.1186/2051-5960-2-9 (2014).
Katsel, P., Li, C. & Haroutunian, V. Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer’s disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer’s disease? Neurochem Res 32, 845-–856, https://doi.org/10.1007/s11064-007-9297-x (2007).
Fyrst, H. & Saba, J. D. An update on sphingosine-1-phosphate and other sphingolipid mediators. Nature chemical biology 6,…
